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SESSION INFORMATION
Background/Purpose: APS ACTION International Clinical Database and Repository was created to
study the natural course of disease over 10 years in persistently antiphospholipid antibody (aPL)-
positive patients with/without other systemic autoimmune diseases (SAIDx). Although, IgA aCL and
IgA aβ GPI were included in the new SLICC systemic lupus erythematosus (SLE) classification
criteria, the prevalence and clinical significance of IgA isotype have been controversial. Thus our
objective was to better define the prevalence and clinical significance of IgA aCL and aβ GPI in
aPL-positive patients with/without SLE.
Methods: A web-based data capture system is used to store patient demographics, aPL-related
history, and medications. The inclusion criteria are positive aPL based on the Updated Sapporo
classification criteria at least twice within one year prior to enrolment. Patients are followed every
12±3 months with clinical data and blood collection. The baseline samples are analysed in the
APS ACTION core laboratories to confirm aPL-positivity. For this cross sectional study, using chi
square test, we compared the demographic and clinical characteristics of aPL-positive patients
with/without SLE based on different aCL/aβ GPI isotypes.
Results: As of April 2016, 638 aPL-positive patients recruited from 24 centers; 489 (77%) had core
laboratory assessments of IgG/M/A aCL/aβ GPI. Forty-two patients were excluded due to the
diagnosis of a SAIDx other than aPL/APS and/or SLE. Thus, 320 (72%) aPL-positive patients without
SLE (258 [81%] with APS) and 127 (28%) with SLE (96 [76%] with APS) were analyzed. The frequency
of aCL and aβ GPI IgG/M/A positivity (defined as > 20U) was not different between the two groups
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of aCL and aβ GPI IgG/M/A positivity (defined as > 20U) was not different between the two groups
except the IgG isotype, which was more common in aPL-positive patients without SLE (53% vs 42%
[p: 0.03] for aCL and 38% vs 21% [p: 0.03] for aβ GPI). However, the frequency of IgA aβ GPI
positivity was 3-fold higher than IgA aCL positivity (33% vs 11% [p<0.001] in those with SLE, and
32% vs 12% in those without SLE [p<0.001]). The demographics and aPL-related clinical
manifestations were not different among aCL/aβ GPI IgG, IgM, and IgA isotypes (Table). The results
were similar when the aCL/aβ GPI ELISA cut-off was set to 40U. Of note, the frequency (%) of
isolated aCL IgG/M/A- and aβ GPI IgG/M/A-positive patients (independent of the LA status) were
22/19/1 and 11/11/8, respectively (when the ELISA cut-off was set to 20U); isolated aβ GPI IgA
positivity was significantly higher in aPL-positive patients with SLE, compared to those without SLE
(p: 0.006).
Conclusion: Although IgA aβ GPI positivity is more common than IgA aCL positivity, especially in
SLE, the aCL/aβ GPI IgA isotype does not distinguish between aPL-positive patients: a)
with/without SLE; and b) with different aPL-related clinical events.
Table: Clinical features of All IgG, IgM and IgA aPL positive patients, cut-off aPL ELISA ≥20u.
n (%) aCL IgG
n=224
aCL IgM
n=200
aCL IgA
n=54
aB GPI
IgG
n=149
aB GPI
IgM
n=135
aB GPI
IgA
n=143
p
Gender    
(F)      
158(70.5) 146 (73) 36 (66.7) 103 (69.1) 94 (69.6) 99 (69.2) 0.986
Caucasian
Black  
Others
143 (63.8)
3 (1.4)
78 (34.8)
135 (67.5)
6 (3)
59 (29,5)
34 (63)
4 (7.4)
16 (29,6)
94 (63.1)
2 (1.3)
53 (35,6)
91 (67.4)
3 (2.2)
41 (30,4)
91 (63.6)
8 (5.6)
44 (30,8)
0.905
Mean Age 46.9±12.1
(18-81)
48.3±12.4
(18-83)
49.1±13.4
(26-81)
46.6±12.1
(18-81)
48.8±13
(18-83)
48.9±12.3
(23-81)
N/A
SLE 53 (23.7) 50 (25) 14 (25.9) 26 (17.4) 32 (23.7) 42 (29.4) 0.305
Thrombosis 133 (57.4) 104 (52) 33 (61.1) 95 (63.7) 71 (52.6) 81 (56.6) 0.237
Obstetric 17 (7.6) 22 (11) 7 (13) 12 (8.1) 11 (8.1) 10 (7) 0.615
Thrombosis
 + Obstetric
35 (15.6) 27 (13.5) 8 (14.8) 19 (12.8) 19 (14.1) 24 (16.8) 0.927
Non-
criteria*
39 (17.4) 47 (23.5) 6 (11.1) 23 (15.4) 34 (25.2) 28 (19.6) 0.093
 *Sapporo Classification Criteria not met
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